| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 11.02.
| Avanir Pharmaceuticals: The Perfect 2012 Stock For Cubs Fans | | - | Seeking Alpha |
| 09.02.
| Avanir AVP-923 shows safety and efficacy results | | 3 | Pharma Bus Review |
| 08.02.
| Is Avanir Pharmaceuticals the Perfect Stock? | | 1 | Motley Fool |
| 08.02.
| Avanir (AVNR) Reports Publication of Superior Results from AVP-923 Phase III Dosage Study | | 1 | StreetInsider.com |
| 08.02.
| Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain | | 43 | PR Newswire |
| ALISO VIEJO, Calif., Feb. 8, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) announced today that the results of the study entitled "Efficacy and Safety of Dextromethorphan/Quinidine...
Mehr lesen zu:
Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain | |
| 08.02.
| AVANIR Pharmaceuticals' CEO Discusses F1Q12 Results - Earnings Call Transcript | | 5 | Seeking Alpha |
| 07.02.
| Avanir Pharmaceuticals Reports Fiscal 2012 First Quarter Financial and Business Results | | 26 | PR Newswire |
| ALISO VIEJO, Calif., Feb. 7, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three months ended December 31, 2011.
Quarterly Financial Highlights
Gross...
Mehr lesen zu:
Avanir Pharmaceuticals Reports Fiscal 2012 First Quarter Financial and Business Results | |
| 30.01.
| Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results and Conference Call | | 51 | PR Newswire |
| ALISO VIEJO, Calif., Jan. 30, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter ended December 31, 2011 after market close on...
Mehr lesen zu:
Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results and Conference Call | |
| 12.01.
| Stock to Watch: AVANIR Pharmaceuticals Up 5.7% | | 12 | SmarTrend |
| 28.12.
| Highlights der US-Vorbörse: Medicis, Avanir Pharma, Morgan Stanley | | 12 | GodmodeTrader.de |
| 28.12.
| AVANIR Pharmaceuticals has the Highest Beta in the Pharmaceuticals Industry | | 6 | SmarTrend |
| 15.12.
| AVANIR Pharmaceuticals: The Losing Streak Continues | | 7 | SmarTrend |
| 13.12.
| AVANIR PHARMACEUTICALS, INC. - 10-K, Annual Report | | 2 | SEC Filings |
| 13.12.
| Avanir Pharmaceuticals mit Verlustausweis | | 100 | BörseGo |
| New York (BoerseGo.de) - Das US-Pharmaunternehmen Avanir Pharmaceuticals hat am Montagabend seine Zahlen zum vierten Geschäftsquartal veröffentlicht. Wie aus der Pressemitteilung hervorgeht, wurden...
Mehr lesen zu:
Avanir Pharmaceuticals mit Verlustausweis | |
| 12.12.
| Avanir Pharma Q4 Loss Widens | | 53 | AFX News |
| WASHINGTON (dpa-AFX) - Avanir Pharmaceuticals, Inc. (AVNR) posted
fourth-quarter net loss of $18.0 million or $0.14 per share, wider than $9.7
million or $0.10 per share in the previous...
Mehr lesen zu:
Avanir Pharma Q4 Loss Widens | |
| 12.12.
| Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results | | 23 | PR Newswire |
| ALISO VIEJO, Calif., Dec. 12, 2011 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today reported financial results for the three and twelve months ended September 30, 2011....
Mehr lesen zu:
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results | |
| 12.12.
| Generex Biotech and Avanir Pharmaceuticals Look to Rally in 2012 / The Paragon Report Provides Equity Research on Generex Biotechnology & Avanir Pharmaceuticals | | 48 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 12/12/11 -- The biotechnology industry has been a strong performer in 2011 as mergers and acquisitions and favorable legislation have propped up the sector. The domestic...
Mehr lesen zu:
Generex Biotech and Avanir Pharmaceuticals Look to Rally in 2012 / The Paragon Report Provides Equity Research on Generex Biotechnology & Avanir Pharmaceuticals | |
| 06.12.
| Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call | | 28 | PR Newswire |
| ALISO VIEJO, Calif., Dec. 6, 2011 /PRNewswire/ --Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) will report financial results for the quarter and year ended September 30, 2011 after market close on Monday...
Mehr lesen zu:
Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call | |
| 22.11.
| Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference | | 21 | PR Newswire |
| ALISO VIEJO, Calif., Nov. 22, 2011 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will participate in the Piper Jaffray 23rd Annual Health Care...
Mehr lesen zu:
Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference | |
| 17.11.
| Avanir Pharma's MAA For NUEDEXTA Accepted By EMA | | 35 | AFX News |
| WASHINGTON (dpa-AFX) - Biopharmaceutical company Avanir Pharmaceuticals Inc
(AVNR) Thursday stated that the European Medicines Agency, or EMA, has accepted
the filing of the Marketing Authorization...
Mehr lesen zu:
Avanir Pharma's MAA For NUEDEXTA Accepted By EMA | |
